International Journal of Pharmaceutics-X

Papers
(The H4-Index of International Journal of Pharmaceutics-X is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Phloretin-nanospanlastics for targeting the Akt/PI3K signaling pathways in dimethylhydrazine-induced colon cancer in mice100
Tailored ASD destabilization - Balancing shelf life stability and dissolution performance with hydroxypropyl cellulose31
Transferrin conjugated pH/NIR-responsive black phosphorus nanoplatform: A novel multimodal approach for breast cancer theranostics26
Tailored transethosomal systems for tadalafil transdermal delivery: Impact of Phosal and edge activators on skin permeation and cellular uptake24
HSPiP and QbD oriented optimized nanocubosomes for ameliorated absorption of tolterodine tartrate: In vitro and in vivo evaluations21
Exploiting recent trends for the synthesis and surface functionalization of mesoporous silica nanoparticles towards biomedical applications20
Rationalized landscape on protein-based cancer nanomedicine: Recent progress and challenges17
Engineering exosomes for cancer therapy - Modification technologies and subcellular targeting strategies: A review16
Exploring high-throughput synchrotron X-Ray powder diffraction for the structural analysis of pharmaceuticals16
Continuous direct compression: Development of an empirical predictive model and challenges regarding PAT implementation15
Modeling of physical-mechanical and microbiological properties of tablets made of complex fluidized bed granules containing living yeast cells using common mixing rules15
Polydopamine-activated celastrol carbon dots for synergistic chemotherapy-photothermal therapy of tumors15
Erratum regarding missing Conflict of Interest statements in previously published articles15
Autoencoder-based inverse design and surrogate-based optimization of an integrated wet granulation manufacturing process15
Everolimus-encapsulation in Pluronic P123 self-assembled micelles as drug delivery systems for drug-coated balloons15
0.14049196243286